Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study
暂无分享,去创建一个
M. Rosińska | A. Borowiec | A. Cieszanowski | Z. Nowecki | A. Jagiełło-Gruszfeld | J. Walewski | A. Żebrowska | K. Gepner | B. Kotowicz | M. Fuksiewicz | H. Koseła-Paterczyk | A. Kapała | E. Lampka | S. Jasek | P. Ozdowska | Joanna Waniewska | Agata Makówka | Magdalena Chojnacka
[1] C. Shenoy,et al. Incidental Coronary Calcium in Cancer Patients Treated with Anthracycline and/or Trastuzumab. , 2022, European journal of preventive cardiology.
[2] I. Cho,et al. Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy , 2022, Breast.
[3] S. Achenbach,et al. Erratum to: Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part I. , 2022, European heart journal. Cardiovascular Imaging.
[4] G. Pontone,et al. Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part I. , 2022, European heart journal. Cardiovascular Imaging.
[5] V. Figueredo,et al. Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy. , 2021, The American journal of cardiology.
[6] Y. Nishimura,et al. Statin Use Can Attenuate the Decline in Left Ventricular Ejection Fraction and the Incidence of Cardiomyopathy in Cardiotoxic Chemotherapy Recipients: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.
[7] A. Partridge,et al. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis , 2021, Cancer Causes & Control.
[8] V. Fuster,et al. Coronary microcirculation damage in anthracycline cardiotoxicity , 2021, Cardiovascular research.
[9] D. Berman,et al. Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium , 2020, American journal of preventive cardiology.
[10] B. Gage,et al. Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study. , 2020, Clinical lymphoma, myeloma & leukemia.
[11] C. Cipolla,et al. Cardiotoxicity of Anthracyclines , 2020, Frontiers in Cardiovascular Medicine.
[12] A. Jabłecka,et al. Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence , 2019, Therapeutics and clinical risk management.
[13] P. Thavendiranathan,et al. Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy. , 2019, The Canadian journal of cardiology.
[14] G. Janbabai,et al. Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial , 2019, Journal of cardiovascular pharmacology and therapeutics.
[15] L. Désaubry,et al. Updates in Anthracycline-Mediated Cardiotoxicity , 2018, Front. Pharmacol..
[16] T. Oka,et al. Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis , 2018, Journal of atherosclerosis and thrombosis.
[17] Catherine R. Lesko,et al. Missingness in the Setting of Competing Risks: from Missing Values to Missing Potential Outcomes , 2018, Current Epidemiology Reports.
[18] G. Fonarow,et al. Statins and the Prevention of Heart Disease. , 2017, JAMA cardiology.
[19] D. Grobbee,et al. Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors , 2016, PloS one.
[20] K. Williams,et al. A comparative assessment of coronary artery calcification on chest CT scans of patients referred to a cardio-oncology clinic , 2016, Cardio-Oncology.
[21] B. Gage,et al. Statins Are Associated With Reduced Mortality in Multiple Myeloma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D. Bruzzese,et al. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy , 2015, Breast Cancer Research and Treatment.
[23] J. Plana,et al. Anthracycline-Induced Cardiomyopathy in Adults. , 2015, Comprehensive Physiology.
[24] W. Hundley,et al. Chronic Statin Administration May Attenuate Early Anthracycline Associated Declines in Left Ventricular Ejection Function , 2014, The Canadian journal of cardiology.
[25] T. Marwick,et al. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. , 2012, Journal of the American College of Cardiology.
[26] M. Turgut,et al. Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[27] M. Desnos,et al. In Vivo Induction of Endothelial Apoptosis Leads to Vessel Thrombosis and Endothelial Denudation: A Clue to the Understanding of the Mechanisms of Thrombotic Plaque Erosion , 2004, Circulation.
[28] M. Ferrière,et al. [Cardiotoxicity of anthracyclines]. , 1993, Archives des maladies du coeur et des vaisseaux.
[29] OUP accepted manuscript , 2021, European Heart Journal - Cardiovascular Imaging.
[30] S. Wann,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2013, European heart journal cardiovascular Imaging.
[31] M. Adamcová,et al. Anthracycline-induced cardiotoxicity. , 2000, Acta medica.
[32] Correction: Pregnancy-Related Thromboembolism , 1997, Annals of Internal Medicine.